Literature DB >> 18095372

Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy.

Chad M Warren1, Grace M Arteaga, Sudarsan Rajan, Rafeeq P H Ahmed, David F Wieczorek, R John Solaro.   

Abstract

Current electrophoretic methods have not been optimized to fully separate post-translationally modified mutant forms of tropomyosin (Tm) from wild-type cardiac samples. We describe here a method employing a modified 2-D PAGE/2-D DIGE protocol, to fully separate native, mutant (E54K), and phosphorylated forms of Tm. Our data demonstrate the first evidence of a significant (approximately 40%) decrease in Tm phosphorylation in transgenic compared to non-transgenic mouse hearts, and indicate that altered phosphorylation may be a significant factor in the linkage of the E54K mutation to dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095372      PMCID: PMC2586826          DOI: 10.1002/pmic.200700772

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  22 in total

1.  The effect of single residue substitutions of serine-283 on the strength of head-to-tail interaction and actin binding properties of rabbit skeletal muscle alpha-tropomyosin.

Authors:  K Sano; K Maeda; T Oda; Y Maéda
Journal:  J Biochem       Date:  2000-06       Impact factor: 3.387

Review 2.  Calcium, thin filaments, and the integrative biology of cardiac contractility.

Authors:  Tomoyoshi Kobayashi; R John Solaro
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

3.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

4.  Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.

Authors:  M Muthuchamy; K Pieples; P Rethinasamy; B Hoit; I L Grupp; G P Boivin; B Wolska; C Evans; R J Solaro; D F Wieczorek
Journal:  Circ Res       Date:  1999-07-09       Impact factor: 17.367

5.  Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I.

Authors:  Joanne Layland; Alison C Cave; Chad Warren; David J Grieve; Emma Sparks; Jonathan C Kentish; R John Solaro; Ajay M Shah
Journal:  FASEB J       Date:  2005-04-26       Impact factor: 5.191

6.  Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation.

Authors:  K A Palmiter; Y Kitada; M Muthuchamy; D F Wieczorek; R J Solaro
Journal:  J Biol Chem       Date:  1996-05-17       Impact factor: 5.157

7.  p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity.

Authors:  Susan Vahebi; Asuka Ota; Manxiang Li; Chad M Warren; Pieter P de Tombe; Yibin Wang; R John Solaro
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

Review 8.  Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype.

Authors:  Houman Ashrafian; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2007-03-09       Impact factor: 24.094

9.  The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation.

Authors:  Brandon J Biesiadecki; Tomoyoshi Kobayashi; John S Walker; R John Solaro; Pieter P de Tombe
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

10.  The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.

Authors:  Mahmooda Mirza; Paul Robinson; Elena Kremneva; O'neal Copeland; Olga Nikolaeva; Hugh Watkins; Dimitry Levitsky; Charles Redwood; Mohammed El-Mezgueldi; Steven Marston
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

View more
  27 in total

1.  Why is it important to analyze the cardiac sarcomere subproteome?

Authors:  R John Solaro; Chad M Warren; Sarah B Scruggs
Journal:  Expert Rev Proteomics       Date:  2010-06       Impact factor: 3.940

2.  Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases.

Authors:  Ziyou Cui; Shannamar Dewey; Aldrin V Gomes
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 3.  Phosphorylation of tropomyosin in striated muscle.

Authors:  David H Heeley
Journal:  J Muscle Res Cell Motil       Date:  2013-06-29       Impact factor: 2.698

4.  Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis.

Authors:  Katherine A Sheehan; Grace M Arteaga; Aaron C Hinken; Fernando A Dias; Cibele Ribeiro; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

5.  Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy.

Authors:  Sudarsan Rajan; Ganapathy Jagatheesan; Natalia Petrashevskaya; Brandon J Biesiadecki; Chad M Warren; Tara Riddle; Stephen Liggett; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

6.  Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.

Authors:  Chehade N Karam; Chad M Warren; Sudarsan Rajan; Pieter P de Tombe; David F Wieczorek; R John Solaro
Journal:  J Muscle Res Cell Motil       Date:  2011-01-09       Impact factor: 2.698

7.  β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.

Authors:  Dennis M Abraham; Robert T Davis; Chad M Warren; Lan Mao; Beata M Wolska; R John Solaro; Howard A Rockman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

8.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

Review 9.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

Authors:  David Barefield; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

10.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.